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Abstract
Background: Periodontitis, the most prevalent chronic inflammatory disease, has been related to cardiovascular
diseases. Autophagy provides a mechanism for the turnover of cellular organelles and proteins through a
lysosome-dependent degradation pathway. The aim of this research was to study the role of autophagy in
peripheral blood mononuclear cells from patients with periodontitis and gingival fibroblasts treated with a
lipopolysaccharide of Porphyromonas gingivalis. Autophagy-dependent mechanisms have been proposed in the
pathogenesis of inflammatory disorders and in other diseases related to periodontitis, such as cardiovascular
disease and diabetes. Thus it is important to study the role of autophagy in the pathophysiology of periodontitis.
Methods: Peripheral blood mononuclear cells from patients with periodontitis (n = 38) and without periodontitis (n =
20) were used to study autophagy. To investigate the mechanism of autophagy, we evaluated the influence of a
lipopolysaccharide from P. gingivalis in human gingival fibroblasts, and autophagy was monitored morphologically and
biochemically. Autophagosomes were observed by immunofluorescence and electron microscopy.
Results: We found increased levels of autophagy gene expression and high levels of mitochondrial reactive
oxygen species production in peripheral blood mononuclear cells from patients with periodontitis compared with
controls. A significantly positive correlation between both was observed. In human gingival fibroblasts treated with
lipopolysaccharide from P. gingivalis, there was an increase of protein and transcript of autophagy-related protein
12 (ATG12) and microtubule-associated protein 1 light chain 3 alpha LC3. A reduction of mitochondrial reactive
oxygen species induced a decrease in autophagy whereas inhibition of autophagy in infected cells increased
apoptosis, showing the protective role of autophagy.
Conclusion: Results from the present study suggest that autophagy is an important and shared mechanism in
other conditions related to inflammation or alterations of the immune system, such as periodontitis.
Background
An appreciation of the rising global burden of chronic,
noncommunicable diseases has grown in the last years.
Cardiovascular disease (CVD) is one of the leading
causes of death and disability worldwide, accounting for
16.7 million (29.2%) of total global deaths [1]. Abundant
evidence has demonstrated that reducing modifiable
CVD risk factors (smoking, lipid fractions, blood
pressure, diabetes) through drug, dietary and other inter-
ventions can prevent or delay CVD events. Although
implementation of clinical preventive guidance is improv-
ing over time, there is still a large proportion of coronary
patients who do not reach the lifestyle, risk factor and
therapeutic targets for CVD prevention [2]. Therefore,
some other approach should be implemented. The new
approach could come from the study of the pathologic
mechanisms involved in CVD.
Periodontitis is generally a chronic disorder character-
ized by the breakdown of tooth-supporting tissues, produ-
cing a loss of dentition. It is the most prevalent chronic
* Correspondence: m.a.battino@univpm.it
6Dipartimento di Scienze Cliniche Specialistiche ed Odontostomatologiche -
Sezione Biochimica, Università Politecnica delle Marche, Via Ranieri, 65,
Ancona, 60100, Italia
Full list of author information is available at the end of the article
Bullon et al. BMC Medicine 2012, 10:122
http://www.biomedcentral.com/1741-7015/10/122
© 2012 Bullon et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
inflammatory human disease, affects 30% to 40% of the
population over 35 years of age, and is considered a major
problem in the global burden of oral diseases [3]. The
cause is an ecological imbalance between the microbial
biofilm on teeth and an impaired host inflammatory
response. The disease involves the breakdown of the
gingival connective tissue, namely gingival fibroblast
dysfunction. It has been related to CVD; for instance,
periodontitis is significantly associated with the risk of
developing cerebrovascular incidents and, in particular,
nonhemorrhagic stroke [4]. In a recent Editor’s Consensus
Report between The American Journal of Cardiology and
Journal of Periodontology, this interrelationship was
reviewed and future research was requested to find the
best management to reduce CVD risk in periodontitis [5].
Inflammation needs the proper functioning of cells. The
degradation of damaged and excess organelles as well as
the elimination of invading pathogens is essential to main-
tain cell homeostasis. Autophagy is the principal catabolic
pathway allowing the cell to survive the stress of these and
other intrinsic and extrinsic insults [6]. The autophagy
machinery interfaces with most cellular stress-response
pathways, including those involved in controlling immune
responses and inflammation [7]. Impaired autophagy is
correlated with various severe pathologies, including cardi-
ovascular and autoimmune diseases [8]. More specifically,
constitutive autophagy in the heart under baseline condi-
tions is a homeostatic mechanism for maintaining cardio-
myocyte size and global cardiac structure and function [9].
The molecular mechanism underlying autophagy has been
extensively researched in the past decade, and the genes
participating in this process, usually named autophagy-
related genes (ATGs) [10], were found to be conserved in
yeast and humans [11,12]. Oxidative stress has been
shown to induce autophagy under starvation and ische-
mia/reperfusion conditions [13,14]. Within most cells, the
mitochondrion is the main source of reactive species
which are by-products of cell energy production. All con-
ditions able to alter mitochondria efficiency can enhance
the production of reactive oxygen species (ROS), having a
direct and critical effect on oxidative stress [15].
Periodontitis as an example of a chronic inflammatory
disease could share autophaghic alterations. On the one
hand, in the oral environment, the inflammatory response
is often evocated by specific bacteria, like Porphyromonas
gingivalis. On the other hand, oxidative stress is one of the
main factors explaining the pathophysiological mechanism
of inflammatory conditions that occur in atherosclerosis
and periodontitis. Several studies have demonstrated an
increase of products from oxidative damage in plasma and
serum in patients with periodontitis compared with
healthy individuals [16,17]. Moreover, there is evidence
both for a decreased antioxidant capacity in patients with
periodontitis, evaluated by different assays [18-20].
Evidence has been found indicating a regulatory role
for ROS of mitochondrial origin as signaling molecules
in autophagy, leading, under different circumstances, to
either survival or cell death [21,22]. Recently, our group
reported high levels of mitochondrial-derived ROS,
accompanied by mitochondrial dysfunction in peripheral
blood mononuclear cells (PBMCs) from patients with
periodontitis [23]. Furthermore, P. gingivalis lipopolysac-
charide (LPS) was found to be responsible for high
mitochondrial ROS and coenzyme Q10 (CoQ10) levels
and for mitochondrial dysfunction because it affected
the amount of respiratory chain complex I and III.
Therefore, LPS-mediated mitochondrial dysfunction
could be the reason for oxidative stress onset in patients
with periodontitis.
The purpose of the present study was two-fold. First,
to investigate if periodontitis, as a chronic inflammatory
disease, modifies the autophagy capacity of PBMCs. Sec-
ond, to elucidate, in an in vitro model with gingival
fibroblasts, in what way bacterial periodontal infection
with P. gingivalis LPS alters autophagy mechanisms, and
if this process should be considered a protective rather
than a pathological mechanism.
Methods
Ethics statement
The study was approved by the Ethics Review Board of the
University of Seville. All the studies involving human par-
ticipants were conducted in full compliance with govern-
ment policies and the Declaration of Helsinki. All
participants completed an informed consent.
Patients
Patients attending Seville University Dental School over a
period of 10 months were invited to participate in the
study. A total of 65 consecutive patients, all over 35 years
old, agreed to participate and signed the written consent
form. Protocol and consent forms had been previously
approved by the Committee of Ethics and Research of
Seville University (16 December 2006). All patients met
the following inclusion criteria: they had more than 20
teeth, they had not taken antibiotics or anti-inflammatory
drugs in the previous six months, they were not affected
by immunodeficiency, and were generally healthy and
had undergone no previous periodontal treatment. Exclu-
sion criteria were acute infectious diseases during the
previous three weeks; past or present neurological, psy-
chiatric, metabolic, autoimmune or allergy-related pro-
blems, undesired habits (for example, smoking, alcohol);
medical conditions that required glucocorticoid treatment
or use of analgesics, statin or antidepressant drugs; past
or current substance abuse or dependence; and preg-
nancy or current breastfeeding. A blood sample was
taken from each patient as they were recruited.
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A baseline periodontal examination was performed, and
a single examiner collected full medical and dental
histories. A single trained dental examiner recorded peri-
odontal data. Periodontal probing depth (PD) from the
gingival margin (GM) to the most apical penetration of
the probe and the position of the GM relative to the
cement enamel junction were measured at six sites per
tooth. Clinical attachment level (CAL) was calculated by
adding GM to PD. PD and CAL were recorded to the
nearest highest millimeter by means of the North Carolina
periodontal probe (Hu-Friedy, Chicago, IL, USA), 15 mm
in length and 0.35 mm in diameter. The proportion of
sites positive for plaque and for bleeding on probing were
obtained for each patient. According to the criteria estab-
lished by Machtei et al. [24], the clinical entity of period-
ontitis is based on the presence of CAL ≥6 mm in two or
more teeth and one or more sites with PD ≥5 mm. Fifty-
eight potential participants met the inclusion criteria and
were enrolled in the study, and seven patients were
excluded: three smoked cigarettes, three were using anti-
depressant treatment, and one was using statins. Patients
were divided into two groups: one with periodontitis (n =
38) and the other without periodontitis (n = 20), who were
healthy controls. Healthy controls had no sign or symptom
of periodontitis, and had a healthy status and were free of
any medication for at least three weeks before the study
began.
Reagents and chmicals
Mitosox, LysoTracker and Hoechst 3342 were purchased
from Invitrogen/Molecular Probes (Eugene, OR, USA);
anti-hATG12 from Biosensis (South Australia, Australia);
anti-MAP LC3 (N-20) from Santa Cruz Biotechnology
(Santa Cruz, CA, USA); a cocktail of protease inhibitors
from Boehringer Mannheim (Indianapolis, IN, USA); and
Immun Star HRP substrate kit from Bio-Rad Laboratories
Inc. (Hercules, CA, USA). Monoclonal anti-actin antibo-
dies, butylated hydroxyanisole (BHA), N-acetylcysteine
(NAC), 3-methyl adenine (3-MeA), trypsin-EDTA solution
and all other chemicals were purchased from Sigma-
Aldrich (St. Louis, MO, USA).
Blood mononuclear cell and fibroblast cultures
Heparinized and coagulated blood samples were col-
lected from each patient, centrifuged at 3800 ×g for
5 min, and plasma and serum stored separately at -80°C.
PBMCs were purified by isopycnic centrifugation using
Histopaque-1119 and Histopaque-1077 (Sigma Chemical
Co., St. Louis, MO, USA).
Human gingival fibroblasts (HGF) isolated from a
healthy 25-year-old man were cultured in D-MEM media
(4500 mg/L glucose, L-glutamine, pyruvate), (Gibco, Invi-
trogen, Eugene, OR, USA) supplemented with 10% FBS
(Gibco) and antibiotics (Sigma Chemical Company). Cells
were incubated at 37°C in a 5% CO2 atmosphere. HGF
were cultured with 10 μg/mL LPS of P. gingivalis (Nucli-
ber S.A., Spain). When required, CoQ10, alpha tocopherol,
BHA and NAC were added to the plates at a final concen-
tration of 30 μM, 10 μM, 40 μM and 10 mM, respectively.
Mitochondrial reactive oxygen species production
Mitochondrial ROS generation in PBMCs and fibroblasts
were assessed by MitoSOX Red, a red mitochondrial
superoxide indicator. MitoSOX Red is a novel fluorogenic
dye recently developed and validated for highly selective
detection of superoxide in the mitochondria of living cells
[25]. MitoSOX Red reagent is live-cell permeant and is
rapidly and selectively targeted to the mitochondria. Once
in the mitochondria, MitoSOX Red reagent is oxidized by
superoxide and exhibits red fluorescence.
Flow cytometry
Approximately 1 × 106 cells were incubated with 1 μM
MitoSOX Red for 30 min at 37°C, washed twice with PBS,
resuspended in 500 μL of PBS and analyzed by flow cyto-
metry in an Epics XL cytometer (Beckman Coulter, Brea,
California, USA; excitation at 510 nm and fluorescence
detection at 580 nm).
Fluorescence microscopy
Cells grown on microscope slides in six-well plates for
24 h were incubated with MitoSOX Red for 30 min at
37°C, washed twice in PBS, fixed with 4% paraformalde-
hyde in PBS for 0.5 h to 1 h, and washed twice with
PBS. Cells were then incubated for 10 min at 37°C with
anti-LC3 antibody (Santa Cruz Biotechnology). Slides
were analyzed by immunofluorescence microscopy
(MitoSOX Red: excitation wavelength = 555/28; emis-
sion wavelength = 617/73).
Western blotting for autophagy protein
Whole cell lysate from HGF was prepared by gently shak-
ing the cells with a buffer containing 0.9% NaCl, 20 mM
Tris-HCl, pH 7.6, 0.1% triton X-100, 1 mM phenylmethyl-
sulfonylfluoride and 0.01% leupeptin. Electrophoresis was
carried out in a 10% to 15% acrylamide SDS-PAGE.
Proteins were transferred to Immobilon membranes
(Amersham Pharmacia, Piscataway, NJ, USA) and, after
blocking overnight at 4°C, incubated with the respective
antibody solution, diluted at 1:1,000. Membranes were
then probed with their respective secondary antibody
(1:2,500). Immunolabeled proteins were detected by using
a chemiluminescence method (Immun Star HRP substrate
kit, Bio-Rad Laboratories Inc.). Protein was determined by
the Bradford method [26].
b-galactosidase test
Autophagy induces an increment of degradative enzymes
mediated by lysosomal activity; therefore, to evaluate
lysosomal b-galactosidase protein, cultured HGF were
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washed in PBS (pH 7.4), fixed with 3.7% formaldehyde
and incubated overnight at 37°C in freshly prepared
staining buffer (1 mg/mL Xgal (5-bromo-4-chloro-3-
indolyl b-D-galactosidase), 5 mM K3Fe[CN]6, 5 mM K4Fe
[CN]6 and 2 mM MgCl2 in PBS, pH 6.0, or in citrate-
buffered saline, pH 4.5). At the end of incubation, cells
were washed with PBS, examined, and photographed
using a Leica CTR 5000 microscope. b-galactosidase
staining was quantified using Image J software (Bethesda,
MD, USA).
LysoTracker Red assay for acidic lysosomes
LysoTracker (100 nM) was added to cultured HGF as a
fluorescent acidotropic probe for labeling and tracking
acidic organelles. After 30 min, cells were harvested, incu-
bated with fresh medium, washed, centrifuged (500 ×g),
and resuspended in DMEM medium. The red fluorescence
of LysoTracker was quantified by flow cytometry in an
Epics XL cytometer (Beckman Coulter; excitation wave-
length: 577 nm, emission wavelength: 590 nm) [27].
Real-time quantitative PCR of autophagy genes
Total cellular RNA was purified from the cultured cells
using the Trisure method (Bioline, London, UK), accord-
ing to the manufacturer’s instructions. RNA concentration
was determined using spectrophotometry. To avoid geno-
mic DNA contamination, one microgram of total RNA
from each sample was incubated in gDNA wipe out buffer
(Quantitect Reverse Transcription Kit, Qiagen, Hilden,
Germany) at 42°C for 5 min. RNA samples were subse-
quently retrotranscribed to cDNA using QuantiTect
Reverse Transcription Kit (Qiagen). Quantitative RT-PCRs
were performed in a miniopticon unit (Bio-Rad) making
use of the SensiMix One-Step qRT-PCR Kit (London,
UK). The thermal cycling conditions used were: denatura-
tion at 95°C for 20 s, alignment at 54°C for 20 s and elon-
gation at 72°C for 20 s, for 40 cycles. Human ATG12
primers 5’-ATTGCTGCTGGAGGGGAAGG-3’ (forward
primer) and 5’-GGTTCGTGTTCGCTCTACTGC-3’
(reverse primer) amplify a sequence of 198 nucleotides.
Human MAP-LC3 primers 5’-GCCTTCTTCCTGCTG
GTGAAC-3’ (forward primer) and 5’-AGCCGTCCTCG
TCTTTCTCC-3’ (reverse primer) amplify a sequence of
91 nucleotides.
Electron microscopy
HGF were fixed for 15 min in the culture plates with 1.5%
glutaraldehyde in culture medium, then for 30 min in
1.5% glutaraldehyde-0.1 M Na cacodylate/HCl, pH 7.4.
They were then washed three times in 0.1 M Na cacody-
late/HCl, pH 7.4 for 10 min and post-fixed with 1% OsO4-
H2O, pH 7.4 for 30 min. After dehydration process during
5 min in each increasing concentrations of ethanol (50%,
70%, 90% and three times 100%), impregnation steps and
inclusion were performed in Epon and finally polymerized
at 60°C for 48 h. An ultramicrotome was used to obtain
60 nm to 80 nm sections (Leica Ultracut S; Leitz Micro-
systems, Wetzlar, Germany) and contrasted with uranyl
acetate and lead citrate. Observations were performed on
a Zeiss LEO 906 E transmission electron microscope
(Zeiss, Oberkochen, Germany).
Proliferation rate
Two hundred thousand HGF were cultured with LPS
(10 μg/mL) in the absence or presence of 3-MeA (20 mM)
for 24 h. After discharging the supernatant with dead cells,
cell counting was performed from three high power fields
using an inverted microscope and a 40× objective.
Analysis of apoptosis
Apoptosis in HGF treated with LPS was assessed by
observing nuclei fragmentation by Hoechst staining
(0.05 μg/ml), as previously described [28].
Statistical analysis
All results are expressed as means ± SD unless stated
otherwise. An unpaired Student’s t test was used to evalu-
ate the significance of differences between groups, accept-
ing P < 0.05 as the level of significance. Statistical analyses
included Pearson’s correlations between mitochondrial
ROS in PBMCs from patients, and MAP-LC3 expression
levels; P < 0.05 were considered significant. Data were ana-
lyzed using the SPSS/PC statistical software package (SPSS
for Windows, 19, 2010, SPSS Inc. Chicago, IL, USA).
Results
Clinical data
Of the 58 patients who met the inclusion criteria and
agreed to participate, 38 were diagnosed with periodonti-
tis. Table 1 summarizes the results of the periodontal
examination with significant differences in all the para-
meters studied (P < 0.001 for GM, PD, CAL, dental plaque
and gingival bleeding determinations) while no significant
differences were found for age and body mass index
between the considered groups.
Reactive oxygen species-dependent autophagy in
patients with periodontitis
Quantification of ROS production by flow cytometry ana-
lysis showed high levels of mitochondrial ROS production
in PBMCs from patients with periodontitis compared with
patients without periodontitis (Figure 1A). To observe the
presence of autophagy in patients with periodontitis, we
analyzed the expression of the gene LC3, which encodes a
protein involved in autophagic processes. PBMCs from
patients with periodontitis showed a significantly increased
expression of MAP-LC3 gene compared with those from
controls (Figure 1B). To further examine the role of ROS
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generation in autophagy present in periodontitis, we statis-
tically analyzed the correlation between both parameters.
A significant positive correlation (r = 0.7881, P < 0.001)
was observed showing the role of ROS in autophagy in
periodontitis (Figure 1C).
Lipopolysaccharide induces autophagy in human
gingival fibroblasts
Activation of LPS-induced autophagy was observed when
analyzing the expression of the genes ATG12 and LC3 by
analyzing mRNA levels and protein expression. HGF trea-
ted with LPS showed a significantly increased mRNA level
for both studied genes, compared with control HGF
(Figure 2A). The protein level of ATG12 was also
increased in LPS fibroblasts (Figure 2B). We investigated
the relative protein abundance of LC3-I and LC3-II, the
ratio of which represents the conversion of LC3-I to L3-II
and is considered a marker of autophagic activity. We
found a significant increase in LC3-II conversion in LPS
HGF, indicating enhanced autophagosome formation
(Figure 2B). Autophagy was further verified under micro-
scopic analysis by increased intensity, due to b-galactosi-
dase and LC3 (Figure 2C). To confirm the presence of
mitochondrial degradation or mitophagy in LPS fibro-
blasts, we performed electron microscopy on control and
LPS-treated fibroblasts. Figure 3 clearly shows the
presence of autophagosomes and laminar bodies in LPS-
treated HGF, indicating extensive autophagy. In early
autophagosomes it is possible to see mitochondria that are
being degraded.
Lipopolysaccharide-induced autophagy in human gingival
fibroblasts depends on reactive oxygen species
To further examine the role of ROS generation in LPS-
induced autophagy, we cultured HGF in the presence
of LPS and, alternatively, four antioxidants: CoQ10, a-
tocopherol, BHA and NAC. We quantified levels of acidic
vacuoles by using Lysotracker staining, mitochondrial
ROS production by MitoSOX and flow cytometry analysis.
We observed that acidic vacuoles and ROS were signifi-
cantly increased in LPS-treated HGF with respect to con-
trols. Interestingly, all antioxidants significantly attenuated
autophagy (Figure 4A) and ROS (Figure 4B). We also
investigated the conversion of LC3-I to LC3-II after anti-
oxidant treatment. Figure 4C shows a significant decrease
in LC3-II conversion in LPS HGF, indicating a reduction
in autophagosome formation. Immunofluorescence stu-
dies, staining with antibodies against LC3, also indicated
that autophagosome accumulation co-localized with a
mitochondrial superoxide marker, such as MitoSOX Red
(Figure 4D).
Lipopolysaccharide-induced autophagy could play a
protective role
To elucidate whether autophagy in LPS-treated HGF was
a protective or a pathological mechanism, we examined
the effect of blocking autophagy by using 3-MeA
(20 mM), a well-characterized inhibitor of the early
stages of autophagy. We examined LPS-treated and con-
trol HGF for viability and apoptosis. Figure 5 clearly
shows that inhibiting autophagy in LPS-treated HGF pro-
vides, as a concomitant result, a significant reduction of
cell viability and an increase of the apoptosis rate.
Discussion
The main finding of the present study is that autophagy
might be an important mechanism involved in chronic
inflammatory diseases like periodontitis. Here, we have
demonstrated, for the first time in patients with periodon-
titis, an enhancement of the autophagy phenomenon
mediated by mitochondrial ROS in PBMCs. Also, our in
vitro gingival fibroblast model showed how the periodontal
etiological agent P. gingivalis LPS led to ROS-mediated
autophagy. Periodontitis represents an example of how the
organism responds to an insult. Here, some bacteria pro-
duce a local disease that may hasten the inflammatory sys-
temic response, inducing and increasing autophagy [7]. In
this situation, cell metabolism is triggered to counteract
the aggression. The key organelle for energy production
and autophagic control in the cell, the mitochondria, is
activated [6]. In fact, it seems that mitochondrial ‘health’
should be fully considered when taking into account an
organism’s capacity to manage these pathological chal-
lenges. This may support the rising interest on the influ-
ence of mitochondria in inflammation-related diseases.
It is well known that the main source of cellular ROS is
mitochondria. Moreover, it has been demonstrated that
mitophagy/autophagy blockade leads to the accumulation
of damaged ROS-generating mitochondria. This in turn
activates the NLRP3 inflammasome which might explain
the frequent association of mitochondrial damage with
inflammatory diseases [29].






Age (years) 40 ± 9 41.1 ± 5
Body mass index (kg/m2) 25.7 ± 1.7 24.6 ± 1.2
Periodontal data
GM (mm) 0.8 ± 0.07a 0.17 ± 0.02
PD (mm) 3.3 ± 0.5a 1.5 ± 0.3
CAL (mm) 4.1 ± 0.3a 2.2 ± 0.3
Dental plaque (%) 48.1 ± 3.7a 21.1 ± 2.2
Gingival bleeding (%) 61.9 ± 4.1a 38.3 ± 4.1
Data represent the mean ± SD. CAL: clinical attachment level; GM: position of
the gingival margin; PD: periodontal probing depth. a Significantly different
periodontitis versus non-periodontitis: P < 0.001.
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Figure 1 Reactive oxygen species production and autophagy in periodontitis patients. (A) ROS production was analyzed in PBMCs from
patients with and without periodontitis by flow cytometry as described in Methods. *P < 0.001 periodontitis versus no periodontitis. (B).
Expression of LC3 transcripts in PBMCs from patients with and without periodontitis assessed by real-time PCR as described in Methods.
*P <0.001 periodontitis versus no periodontitis. (C) Correlation between ROS levels and MAP-LC3 mRNA levels in PBMCs from patients with
periodontitis. Data represent the mean ± SD of three separate experiments. non perio: participants without periodontitis; PBMC: peripheral blood
mononuclear cells; perio: patients with periodontitis; ROS: reactive oxygen species; SD: standard deviation.
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Figure 2 Autophagy in human gingival fibroblasts treated with lipopolysaccharide (10 μg/mL). (A) mRNA levels of ATG12, and LC3 in
control and LPS-treated fibroblasts. Statistical significance: *control versus LPS-treated HGF (P < 0.01) (B) Protein expression of Atg12 and LC3.
Protein levels were determined by densitometric analysis of three different western blots and normalized to GADPH signal.*P < 0.01, between
control and LPS-treated fibroblasts. (C) Representative images of autophagic markers (LC3, b-galactosidase) in control and LPS-treated fibroblasts
that were visualized by immunofluorescence and light microscopy respectively, as described in Methods. Bar = 25 μm. Data represent the
mean ± SD of three separate experiments. CTL: control; IOD: integrated optical intensity; LPS: lipopolysaccharide.
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Recently, our group described that PBMCs from patients
with periodontitis have a mitochondrial dysfunction char-
acterized by lower CoQ10 levels and citrate synthase activ-
ity, together with high levels of ROS production [23]. Also,
we described that LPS-treated gingival fibroblasts raised
oxidative stress and led to mitochondrial dysfunction in
terms of lower protein expression, loss of mitochondrial
mass and impaired membrane potential. These results
agree with data from the present study in which the influ-
ence of periodontitis in modifying systemic defense
mechanisms, plus other local effects at the gingival level,
leads to enhanced ROS production. It has been reported
that ROS production and oxidative stress are a common
consequence of dysfunctional mitochondria and play
important roles in the development of autophagy [8]. We
found increased expression of autophagy-related mRNA
and proteins, demonstrating the activation of autophagy
after ROS enhancement that occurred after mitochondrial
dysfunction induced by P. gingivalis LPS. Moreover, lyso-
somal and autophagic markers (b-galactosidase, LC3 and
LysoTracker staining) were higher in treated fibroblasts,
indicating lysosomal proliferation. We confirmed these
results by electron microscopy, which clearly showed the
presence of laminar bodies and autophagosomes engulfing
mitochondria.
Autophagy is a process by which cytosol and organelles
are sequestered within double-membrane vesicles, deliver-
ing their contents for lysosome/vacuole degradation,
followed by recycling of resulting materials [30]. The induc-
tion of autophagy could be part of the cellular program
leading to cell death, or it could reflect attempts by the cell
to repair itself through the removal of damaged organelles.
In this sense, autophagy might be induced to aid in remov-
ing damaged mitochondria. In the present study, we
observed an important activation of autophagy-related
mRNA and proteins after P. gingivalis LPS induction.
Furthermore, we also confirmed by immunofluorescence
that autophagosome markers such as LC3, co-localized
with cytochrome c, a mitochondrial marker, and b-galacto-
sidase, a typical lysosomal enzyme. These results agree with
previous studies in which LPS-induced inflammation led to
autophagy overexpression, both in cultured cardiomyocytes
of adult rats [31] as well as in rat liver tissue [32].
To test if LPS treatment activated autophagy via the
induction of ROS production, we cultured LPS-treated
HGF with CoQ10, a-tocopherol, BHA and NAC, all of
them very efficient antioxidants. It is worthwhile to under-
line that CoQ10 could act as a key molecule in this context
for cell well-being, both for its antioxidant properties [33]
and for its essential redox role in the mitochondrial
respiratory chain [34]. Results showed that all antioxidants
significantly reduced acidic vacuoles induced by treatment
with LPS. As stated before, we previously established the
relationship between LPS treatment and HGF and ROS
[23]. In a recent investigation, a similar finding was also
described in hepatic mitochondria from mice treated with
a single dosage of LPS. The authors found that LPS
administration affected mtDNA and eventually mitochon-
drial function, while the use of antioxidant treatments
with Mn-Superoxide Dismutase, nitric oxide synthase
inhibitors, superoxide or peroxynitrite scavengers pre-
vented the above mentioned effects. Noteworthy, in our
study, is that treatment with antioxidants also significantly
decreased conversion of LC3-I to LC3-II, suggesting a
reduction in autophagosome formation. CoQ10 and
a-tocopherol, both lipophilic antioxidants, were more effi-
cient in significantly attenuating ROS production, thus
confirming the importance of ROS generated in the lipo-
philic environment of mitochondrial membranes. In the
work by Choumar et al. [34], a role of superoxide anion
(O2•¯), reacting with nitric oxide to form mtDNA and pro-
tein-damaging peroxynitrite, was pointed out. Recently,
Figure 3 Ultrastructure of lipopolysaccharide-treated human gingival fibroblasts (10 μg/mL). Control fibroblasts show mitochondria with
typical ultrastructure. Laminar bodies and autophagosome with mitochondria were present in LPS-treated fibroblasts (black arrow); Bar = 500
nm. LPS: lipopolysaccharide.
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Figure 4 Action of antioxidants on human gingival fibroblast-related autophagy and mitochondrial co-localization of lysosomal
markers of autophagy. (A) Quantification of acidic vacuoles in control and LPS-treated fibroblasts by Lysotracker staining and flow cytometry
analysis after antioxidant treatment.*P < 0.01 between control and LPS-treated fibroblasts.**P < 0.01 between LPS-treated fibroblasts and LPS +
antioxidants. (B) Quantification of mitochondrial ROS in control and LPS-treated fibroblasts by MitoSOX staining and flow cytometry analysis after
antioxidant treatment.*P < 0.01 between control and LPS-treated fibroblasts.**P < 0.01 between LPS-treated fibroblasts and LPS + antioxidants.
(C) Protein expression of LC3 in HGF treated with LPS 10 μg/mL and antioxidants performed by western blotting as described in Methods. **P <
0.001 between LPS-treated fibroblasts and LPS + antioxidants. (D) Mitochondrial-induced ROS degraded by autophagy. Mitochondrial ROS
production was localized by Mitosox Red staining. Cells were then harvested, fixed and immunostained with LC3 (autophagosome marker) and
examined in a fluorescence microscope as described in Methods. Data represent the mean ± SD of three separate experiments. a-toc: a-
tocopherol; BHA: butylated hydroxyanisole; CTL: control; CoQ10: coenzyme Q10; HGF: human gingival fibroblasts; LPS: lipopolysaccharide; NAC:
N-acetylcysteine.
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O2•¯ has been proposed as the major ROS regulating
autophagy [35]. These are new indications about the
importance of proper preservation of structure and func-
tion of cell mitochondria. In this way, mitochondrial
damage might lead to further enhanced ROS production,
resulting in a downward spiral where mitochondrial viabi-
lity is concerned. In turn, the accumulation of dysfunc-
tional mitochondria is a very critical step because it is
related to aging, cancer and neurodegenerative diseases
[36].
Autophagy is like a double-edged sword, playing a role
in cell survival as well as in cell death. It promotes cell
death in some settings, but acts as a protective response
in others. Thus, it is believed that selective mitochondrial
autophagy (mitophagy) contributes to the maintenance
of mitochondrial quality by eliminating damaged mito-
chondria or their excessive number [34], although little is
known about this mechanism. It has been proposed that
autophagy might act as an adaptive mechanism, defend-
ing organisms against the inflammatory process, and
could be the background converging point with CVD. It
may constitute an important physiological or pathophy-
siological response to cardiac stress, such as ischemia or
pressure overload, which are frequently encountered in
patients with coronary artery disease, hypertension, aortic
valvular disease and congestive heart failure. The accu-
mulation of autophagosomes has been noted in cardiac
biopsy tissues of patients with these disorders, rodent
models of these cardiac diseases, and isolated stressed
cardiomyocytes [37]. Inhibition of autophagy in the heart
induces age-related cardiomyopathy in experimental ani-
mals [38]. By contrast, induced autophagy in athero-
sclerosis plaque cells is a survival pathway in plaque
stability and rupture [39]. Consistent with what has been
mentioned above, previous studies have supported the
hypothesis that autophagy has a protective role in LPS-
induced injury in cardiomyocytes [40]. In agreement with
this hypothesis on the protective role of autophagy, the
present research demonstrates that disruption of autop-
hagic processing by 3-MeA leads to cell death.
Given our results, we could hypothesize that mitochon-
drial dysfunction could represent a possible common
functional derangement linking different inflammatory
diseases such as periodontitis and CVD. In this sense, it
could be a common event in all patients with periodonti-
tis, namely a possible risk factor: in fact, mitochondria play
an important role in proinflammatory signaling and ROS
production that has also been shown to be an important
activator of inflammasome-mediated inflammation [28].
Autophagic turnover of cellular constituents, either gen-
eral or specific for mitochondria (that is, mitophagy), elim-
inates dysfunctional or damaged mitochondria, thus
counteracting degeneration, dampening inflammation
and preventing unwarranted cell loss. To the best of our
knowledge, this is the first time autophagy activation has
been described in patients with periodontitis.
Conclusions
The demonstrated importance of autophagy in inflamma-
tory conditions such as CVD, together with the role that
this physiological process exerts in infective conditions,
should be considered in relation to public health manage-
ment. Control of autophagy has been considered as a new
therapeutic approach in CVD and cancer [8]. Results
from the present study suggest that autophagy is also an
important mechanism in other conditions related to
inflammation or alterations of the immune system, such
as periodontitis. The link between periodontitis and CVD
has been fully established in recent years. In fact, the
mouth is a very accessible part of the body, offering an
easy way of obtaining biological samples such as saliva or
epithelial cells. Accordingly, HGFs could represent a
good way to test the systemic status of the organism in
relation to autophagy and consequently to understand
Figure 5 Indices of cell viability and apoptosis in control and
lipopolysaccharide-treated fibroblasts after autophagy arrest
by 3-methyl adenine (20 mM). Results are expressed as mean ±
SD of three independent experiments. *P < 0.01 between control
and LPS-treated fibroblasts. CTL: control: LPS: lipopolysaccharide.
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more about inflammation and inflammatory related
diseases.
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